Acomplia for sale is available in the UK, Germany, Ireland, Argentina, Holland, Finland, Sweden amid other countries. Spain and Italy are the prospective countries where Acomplia may be made available for sale in the year 2007.

Despite the benefits of Acomplia, its launch in the US weight loss market is still awaited due to the stalled FDA approval. Until Acomplia (Rimonabant) receives FDA approval , obese and over weight in the US just have to remain a little patient.

In the 2years of clinical trials, usage of Rimonabant (Acomplia) displayed positive weight loss results. The Acomplia oral medication is usually accompanied with proper diet plan and regular workout regime. Usual recommended dosage for Acomplia (Rimonabant) diet pill is 20mg, which should be followed in strict obedience to a doctor’s prescription.

Women  planning pregnancy, pregnant women, nursing mothers, diabetics , heart patients, and children should keep away from intake of Acomplia (Rimonabant) diet drug. The doctors hold be informed about the entire medical history of Acomplia consumer so as to avert any future medical     

Buy Acomplia for Europe only € 142.55

Buy Acomlia for USA only $245.00

This long awaited weight loss in the US market is developed by French drug maker, Sanofi-Aventis with Rimonabant as its active ingredient. It works on the principle of suppressing the normal appetite. The CB-1 receptors located in the Endo-cannabinoid (EC) system, are responsible for food consumption of the body. Consumption of Acomplia basically obstructs the over-activity of CB-1 receptors amongst obese. In this way, you tend to reduce your appetite and thereby eat in small portions. This whole process is in an effectual for weight loss.